We are live on
!
Find out more
Regeneron Pharmaceuticals
REGN
REGN
1,017 hedge funds and large institutions have $54.4B invested in Regeneron Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 132 funds opening new positions, 408 increasing their positions, 328 reducing their positions, and 73 closing their positions.
New
Increased
Maintained
Reduced
Closed
81% more first-time investments, than exits
New positions opened: 132 | Existing positions closed: 73
24% more repeat investments, than reductions
Existing positions increased: 408 | Existing positions reduced: 328
10% more capital invested
Capital invested by funds: $49.6B → $54.4B (+$4.79B)
5% more funds holding
Funds holding: 971 → 1,017 (+46)
0.94% more ownership
Funds ownership: 85.07% → 86.01% (+0.94%)
6% less funds holding in top 10
Funds holding in top 10: 18 → 17 (-1)
20% less call options, than puts
Call options by funds: $1.16B | Put options by funds: $1.44B
Holders
1,017
Holders Change
+46
Holders Change %
+4.74%
% of All Funds
17.8%
Holding in Top 10
17
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-5.56%
% of All Funds
0.3%
New
132
Increased
408
Reduced
328
Closed
73
Calls
$1.16B
Puts
$1.44B
Net Calls
-$285M
Net Calls Change
-$76M
Top Buyers
| 1 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$251M |
| 2 |
BlackRock
New York
|
+$207M |
| 3 |
JP Morgan Chase
New York
|
+$195M |
| 4 |
Amundi
Paris,
France
|
+$140M |
| 5 |
SGH
Sivik Global Healthcare
Greenwich,
Connecticut
|
+$99.3M |
